Jo SY - Search Results

1

Profiling of conditionally reprogrammed cell lines for in vitro chemotherapy response prediction of pancreatic cancer.

Lee HS, Kim E, Lee J, Park SJ, Hwang HK, Park CH, Jo SY, Kang CM, Hong SM, Kang H, Jo JH, Cho IR, Chung MJ, Park JY, Park SW, Song SY, Han JM, Kim S, Bang S. Lee HS, et al. Among authors: jo jh, jo sy. EBioMedicine. 2021 Mar;65:103218. doi: 10.1016/j.ebiom.2021.103218. Epub 2021 Feb 25. EBioMedicine. 2021. PMID: 33639403 Free PMC article.

2

Impact of mouse contamination in genomic profiling of patient-derived models and best practice for robust analysis.

Jo SY, Kim E, Kim S. Jo SY, et al. Genome Biol. 2019 Nov 11;20(1):231. doi: 10.1186/s13059-019-1849-2. Genome Biol. 2019. PMID: 31707992 Free PMC article.

3

Genomic and transcriptomic profiling reveal molecular characteristics of parathyroid carcinoma.

Jo SY, Hong N, Lee S, Jeong JJ, Won J, Park J, Kim GJ, Kim SK, Kim S, Rhee Y. Jo SY, et al. Exp Mol Med. 2023 May;55(5):886-897. doi: 10.1038/s12276-023-00968-4. Epub 2023 May 1. Exp Mol Med. 2023. PMID: 37121965 Free PMC article.

4

Comprehensive benchmarking and guidelines of mosaic variant calling strategies.

Ha YJ, Kang S, Kim J, Kim J, Jo SY, Kim S. Ha YJ, et al. Among authors: jo sy. Nat Methods. 2023 Dec;20(12):2058-2067. doi: 10.1038/s41592-023-02043-2. Epub 2023 Oct 12. Nat Methods. 2023. PMID: 37828153 Free PMC article.

5

Taxotere Induces Dephosphorylation of MET in Patient-derived Tumor Models.

Mun H, Lee SH, Lee CH, Jo SY, Oh JH, Lee A, Lee B, Jang SJ, Suh YA. Mun H, et al. Among authors: jo sy. Anticancer Res. 2020 Jan;40(1):109-119. doi: 10.21873/anticanres.13932. Anticancer Res. 2020. PMID: 31892559

6

Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death.

Park SJ, Jo DS, Jo SY, Shin DW, Shim S, Jo YK, Shin JH, Ha YJ, Jeong SY, Hwang JJ, Kim YS, Suh YA, Chang JW, Kim JC, Cho DH. Park SJ, et al. Among authors: jo ds, jo yk, jo sy. Oncotarget. 2016 Oct 4;7(40):65957-65967. doi: 10.18632/oncotarget.11781. Oncotarget. 2016. PMID: 27602754 Free PMC article.

7

Inhibition of IL-6/STAT3 axis and targeting Axl and Tyro3 receptor tyrosine kinases by apigenin circumvent taxol resistance in ovarian cancer cells.

Suh YA, Jo SY, Lee HY, Lee C. Suh YA, et al. Among authors: jo sy. Int J Oncol. 2015 Mar;46(3):1405-11. doi: 10.3892/ijo.2014.2808. Epub 2014 Dec 23. Int J Oncol. 2015. PMID: 25544427

8

PPARγ sumoylation-mediated lipid accumulation in lung cancer.

Phan ANH, Vo VTA, Hua TNM, Kim MK, Jo SY, Choi JW, Kim HW, Son J, Suh YA, Jeong Y. Phan ANH, et al. Among authors: jo sy. Oncotarget. 2017 Jul 31;8(47):82491-82505. doi: 10.18632/oncotarget.19700. eCollection 2017 Oct 10. Oncotarget. 2017. PMID: 29137280 Free PMC article.

9

Correction: PPARγ sumoylation-mediated lipid accumulation in lung cancer.

Phan ANH, Vo VTA, Hua TNM, Kim MK, Jo SY, Choi JW, Kim HW, Son J, Suh YA, Jeong Y. Phan ANH, et al. Among authors: jo sy. Oncotarget. 2019 Feb 15;10(14):1473. doi: 10.18632/oncotarget.26710. eCollection 2019 Feb 15. Oncotarget. 2019. PMID: 30858930 Free PMC article.

10

Suppression of gain-of-function mutant p53 with metabolic inhibitors reduces tumor growth in vivo.

Jung CL, Mun H, Jo SY, Oh JH, Lee C, Choi EK, Jang SJ, Suh YA. Jung CL, et al. Among authors: jo sy. Oncotarget. 2016 Nov 22;7(47):77664-77682. doi: 10.18632/oncotarget.12758. Oncotarget. 2016. PMID: 27765910 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page